期刊名称：CONGENITAL HEART DISEASE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Congenital Heart Disease: Clinical Studies from Fetus to Adulthood is a new, clinical journal focusing on congenital heart disease in children and adults. Though the number of infants born with heart disease each year is relatively small (approximately 1% of the population), advances in the treatment of such malformations have led to increased life spans for this population. Consequently, in the United States today most patients treated for congenital heart disease are over the age of 20. What are the special needs of adults with congenital heart disease? What are the latest developments in the care of the fetus, infants, and children? Who should treat these patients? How should they be treated?
Congenital Heart Disease focuses on these questions and more. Conceived as a forum for the most up-to-date information on congenital heart disease, the journal is led by Editor-in-Chief Douglas S. Moodie, MD, Chairman of the Department of Pediatrics at Ochsner Clinic in New Orleans, as well as an international editorial board. Congenital Heart Disease publishes articles on heart disease as it relates to the following areas:
Clinical pediatric and adult cardiology
Cardiac imaging
Preventive cardiology
Diagnostic and interventional cardiac catheterization
Electrophysiology
Surgery
Long-term follow-up, particularly as it relates to older children and adult congenital heart disease
Exercise and exercise physiology in the congenital patient
Post-op and critical care
Common disorders such as syncope, chest pain, murmurs, as well as acquired disorders such as Kawasaki syndrome
The journal includes clinical studies, invited editorials, state-of-the-art reviews, case reports, articles focusing on the history and development of congenital heart disease, and CME material. Occasional issues focus on special topics.
Abstracting and Indexing Information
Academic Search (EBSCO)
Current Contents: Clinical Medicine (Thomson Reuters)
Embase (Elsevier)
MEDLINE (NLM)
Science Citation Index Expanded™ (Thomson Reuters)
Instructions to Authors
Manuscript Submissions
All manuscripts should be submitted online using Manuscript Central. Please follow instructions to 'create an account' located at the top of the right side of the page. You will only need to create an account one time. After you have created your account you can submit your article for consideration for publication in Congenital Heart Disease by logging into the manuscript site using the user ID and password that you created.
Ethical Policy and Guidelines
CHD encourages its contributers and reviewers to adopt the standards of the International Committee of Medical Journal Editors,
which are published in: Uniform Requirements for Manuscripts Submitted to Biomedical Journals, Annals of Internal Medicine 1997; 126:36-47 (icmje.org). CHD will not consider papers that have been accepted for publication or published elsewhere. Copies of existing manuscripts with potentially overlapping or duplicative material should be submitted together with the manuscript, so that the Editors can judge suitability for publication. The Editors reserve the right to reject a paper on ethical grounds.
Authors are expected to disclose, on the title page of their manuscripts, any commercial or other associations that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work, and institutional or corporate affiliations of the authors, should be acknowledged on the title page. These statements will be published in the journal.
For investigations involving humans, the consent of patients and approval of the protocol by an ethical committee should be confirmed. Original textual matter quoted from other authors must have formal citation and be appropriately attributed and referenced. Any statements that might be construed as defamatory must be avoided.
Blackwell is a member of the UK Committee on Publication Ethics. When reporting research on human subjects, the work must comply with the principles of the Declaration of Helsinki (1964) (British Medical Journal, 1964, ii, 177). Authors should indicate that ethical approval of the study was granted, and where appropriate, that informed consent was given. Experiments using human tissue must be shown to comply with national and local ethical guidelines. Experiments using animal models must also be shown to comply with national guidelines and legislation.
For more detailed ethical guidelines, please visit: http://www.blackwellpublishing.com/Publicationethics/
Copyright Transfer Agreement
Authors will be required to sign a Copyright Transfer Agreement (CTA). The CTA allows authors to retain copyright of their article while granting the publisher an exclusive license to publish the article in print and online, to administer rights, and to follow up on any infringements of copyright. Manuscripts will not be sent to the publisher for production until a CTA has been signed and submitted. Please submit a completed, signed CTA when submitting an article for publication. The is available at: http://media.wiley.com/assets/1540/86/ctaaglobal.pdf.
Manuscripts will be considered in the form of:
Clinical Investigations: Present results of original clinical research.
Case Reports: Describe a single case or a small series. They must be educational and draw attention to important or unusual clinical situations, new treatments, or complications.
Brief Research Report: Brief reports of promising or new research (6–12 pages in length).
Reviews: Comprehensive surveys covering a broad area. They consolidate old ideas and may suggest new ones. They must provide a critique of the literature.
Special articles: On subjects not easily classified above (e.g., articles on history, education, demography, ethics, socioeconomics, etc.).
State-of-the-art articles: Articles providing an update on the latest developments in a particular area related to congenital heart disease (6–12 pages in length).
Commentary: Invited as a companion to a full article presenting an alternative or a complimentary perspective.
Editorial: Opinion or perspective on the content of Congenital Heart Disease or of relevance to the field of congenital heart disease.
Letters to the Editor: These may offer criticism or commentary of published material, but must be objective, constructive, and educational. A few references, a small table, or relevant illustrations may be used.
Supplementary Video Clips: Congenital Heart Disease will accept appropriate video clips (cine angiograms, MRIs, etc.) to be posted online as part of an article. Each clip should be less than 10 MB, preferably less than 5 MB. Format and content of all supplementary video clips is the responsibility of the author(s). The Editorial Office and the Publisher will not make any revisions to the material. Clips should be submitted at the same time as the article and will be peer-reviewed. Please send all clips to the Editorial Office on a CD:
Congenital Heart Disease
Poydras Executive Suites
650 Poydras Street
Suite 1431
New Orleans, Louisiana 70130-1400
USA
Manuscript format
Make sure the file is double-spaced and has no hard returns at the end of lines. Ragged right margins are preferable to justified lines. All textual elements should begin flush left with no paragraph indents and two returns after every element, such as titles, headings, paragraphs, legends, etc. Please be sure to keep a back up copy of the file for reference, as accepted manuscripts are not returned. The first text page should contain:
1. Title
2. Full names and affiliations for all authors, including the highest academic degree
3. Full postal address, telephone number, fax number, and e-mail address for the corresponding author, to whom the proofs will be sent
4. Running title of no more than 6 words.
Authors: Names department(s) and institution(s) of all authors. Credit for authorship should be based on: [1] substantial contributions to research design, or the acquisition, analysis or interpretation of data; [2] drafting the paper or revising it critically; [3] approval of the submitted and final versions. Authors should meet all three criteria.
Corresponding author: Name, address, email address, telephone and fax numbers. (Corresponding author should take responsibility for communicating with all other authors and getting their approval for the final version to be published. During online submission corresponding authors can nominate an individual, who may or may not be an author, to assist them with administration of the publication process.)
Author contributions:Recommendation: Include a short description of each authors’ contribution immediately before your references. (Examples of categories for authors’ contributions: Concept/design, Data analysis/interpretation, Drafting article, Critical revision of article, Approval of article, Statistics, Funding secured by, Data collection, Other.)
Abstracts: The abstract, on the page following the title page, must be 300 words or less, under the following headings, as appropriate: Objective, Design, Setting, Patients, Interventions, Outcome Measures, Results, and Conclusions (JAMA 1992;267:42–44). Abstracts are necessary for all papers. The abstracts for Case Reports and Reviews should be unstructured, without the above headings. Up to six key words must be provided with the abstract.
Research papers should be structured as follows: Title page, as above; Abstract; Introduction; Methods; Results; Discussion; Acknowledgments (optional), References; Tables; Figure legends (double-spaced); Figures.
Other articles: The above format may be varied between the Introduction and Acknowledgments sections for other articles.
Details of Style: Follow guidelines set by American Medical Association Manual of Style, Ninth Edition, Lippincott Williams and Wilkins, 1998. Double-spaced throughout, including title page, abstract, text, acknowledgments, references, legends for illustrations, and tables. Start each of these sections on a new page, numbered consecutively in the upper right-hand corner, beginning with the title page.
The body of the text must be in the following sequence: Introduction, Methods, Results, Discussion, and Conclusions.
Drug names: Use generic names only in referring to drugs. If the trade name is necessary, e.g., in bio-availability studies, indicate it in parentheses.
Abbreviations: Keep abbreviations to the minimum, and define each at its first use. Do not use abbreviations in the abstract.
References: References for Congenital Heart Disease should follow the Vancouver (or numerical) system. Identify with Arabic numerals inside parentheses. A full list of references should be provided in numerical order, sequentially as they appear in the text. Do not alphabetize.
Use the Index Medicus reference style (see Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Ann Intern Med 1988;108:258-65). For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. Provide names of all authors, full article titles and inclusive pages. Accuracy of reference data is the responsibility of the author.
Journal article:
1. Author AB, author CD. Title of paper. J Title Abbrev 1994;00:000–00.
Article in edited book:
2. Author AB, Author CD, Author EF. Chapter title. In: Editor AB, Editor CD, eds. Title of Book. Place: Publisher, 1994:000–00.
Book:
3. Author AB. Book Title, 5th edn. Place: Publisher, 1994.
Tables: All tables should be double-spaced. Title all tables, and number them in order of their citation in the text. Any notes should appear at the bottom of the table.
Illustrations: A legend should be provided for each illustration. Photomicrographs should state the original magnification. Legends should provide sufficient information to allow the reader comprehension without reference to the text, and should be grouped at the end of the manuscript. Illustrations should be referred to in the text as “Figs” and be given Arabic numbers. Lines should be of sufficient thickness to stand reduction (no less than 4 mm wide for a 50% reduction), and letters should be a minimum of 9 pt Arial or an equivalent size. There are three preferred formats for digital artwork submission: Encapsulated PostScript (EPS), Portable Document Format (PDF), and Tagged Image Format (TIFF). We suggest that line art be saved as EPS files. Alternately, these may be saved as PDF files at 600 dots per inch (dpi) or better at final size. Tone art, or photographic images, should be saved as TIFF files with a resolution of 300 dpi at final size. For combination figures, or artwork that contains both photographs and labeling, we recommend saving figures as EPS files, or as PDF files with a resolution of 600 dpi or better at final size. More detailed information on the submission of electronic artwork can be found at www.blackwellpublishing.com/authors/digill.asp
Color Illustrations: It is the policy of Congenital Heart Disease for authors to pay the full cost for the reproduction of their color artwork ($800 per journal page of color). Therefore, please note that if there is color artwork in your manuscript when it is accepted for publication, Wiley-Wiley-Blackwell requires you to complete and return a color work agreement form before your paper can be published. This form will be sent to you upon acceptance of your paper.
Electronic Artwork: If submitting final artwork electronically, please read the information on the Blackwell Publishing website at http://www.blackwellpublishing.com/authors/submit_illust.asp. Vector graphics (e.g., line artwork) should be saved in Encapsulated Postscript Format (EPS) and bitmap files (e.g. photographs) should be saved in Tagged Image File Format (TIFF). Line art must be scanned at a minimum of 800 dpi; photographs at a minimum of 300 dpi.
Proofs: The corresponding author will receive an e-mail alert containing a link to a website. A working e-mail address must therefore be provided for the corresponding author. In addition, please provide a second email address for yourself or a co-author, in case we have trouble reaching you at the first email address. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following website: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen, and printed.
Further instructions will be sent with the proof. Hard copy proofs will be posted if no e-mail address is available. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charged separately.
Policy on Review of Page Proofs: Manuscripts for Congenital Heart Disease are copyedited by a professional copyeditor hired by the publisher. The Editor will not check the typeset proofs of accepted manuscripts for errors, thus it is the responsibility of the primary author of each paper to review page proofs carefully for accuracy of citations, formulas, etc., and to check for omissions in the text. It is imperative that the author do a prompt, thorough job of reviewing the returned proofs. Page proofs must be returned to the publisher within 48 hours of receipt. An order form for offprints will be available with proofs.
Free access to the final PDF offprint of your article will be available via author services. Please sign up for author services if you would like to access your article PDF offprint upon publication of your paper, and enjoy the many other benefits the service offers. Visit http://authorservices.wiley.com/bauthor/ to sign up for author services.
Manuscript Checklist:
Submit manuscript, tables, and figures online via Manuscript Central.
Put references in proper format in numerical order, making sure each is cited in the text.
Provide an abstract (250 words or less) with appropriate headings.
Include complete consent forms for patient photographs. See the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org; section II.E.1).
Include consent forms for previously published illustrations and tables.
Designate a corresponding author and provide an address, telephone number, fax number, and e-mail address.
Complete disclosure form and acknowledgment of support.
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.
Editorial Board
Editor-in-Chief
Douglas S. Moodie, MD, MS
Texas Children's Hospital
Houston, TX
Associate Editor-in-Chief
Daniel J. Penny, MD, PhD
Texas Childrens Hospital
Houston, TX
Managing Editor
Brian Coughlin
Malden, MA
Editorial Assistant
Cheryl Moodie
Houston, TX
Advisory Board
Robert Beekman III,
Cincinnati, OH
John P. Cheatham
Columbus, OH
Steven Colan
Boston, MA
Steven R. Daniels
Denver, CO
David J. Driscoll
Rochester, MN
Mark A. Fogel
Philadelphia, PA
Charles Fraser
Houston, TX
Mark Galantowicz
Columbus, OH
Ziyad M. Hijazi
Chicago, IL
Richard A. Humes
Detroit, MI
Thomas Klitzner
Los Angeles, CA
Dennis Mello
New Orleans, LA
W. Robert Morrow
Little Rock, AR
Daniel J. Murphy Jr.
Palo Alto, CA
Christopher J. Petit
Houston, TX
Joseph Rossano
Houston, TX
Gerald Serwer
Ann Arbor, MI
Shaun Setty,
Long Beach, CA
Samuel Siu
Toronto, Ontario, Canada
Chris Snyder
New Orleans, LA
Richard Sterba
Cleveland, OH
Jeffrey Towbin
Houston, TX
Gary Webb
Philadelphia, PA
Steve A Webber
Pittsburgh, PA
Gil Wernovsky
Philadelphia, PA
Editorial Board
Vera Demarchi Aiello
Sao Paulo, SP, Brazil
David Balzer
St. Louis, MO
Lee Benson
Toronto, Ontario, Canada
Edward Bove
Ann Arbor, MI
Robert M. Campbell
Atlanta, GA
Kathleen E. Carberry
Houston, TX
Reuy-Kang R. Chang
Los Angeles, CA
William R. Davidson
Lebanon, PA
Anne M. Dubin
Palo Alto, CA
Gregory Ensing
Ann Arbor, MI
David Fixler
Dallas, TX
Mark A. Fogel
Philadelphia, PA
Thomas Forbes
Detroit, MI
Michael D. Freed
Boston, MA
Howard P. Gutgesell
Charlottesville, VA
Fukiko Ichida
Toyama, Japan
D. Dunbar Ivy
Denver, CO
Henri Justino
Houston, TX
Ronald J. Kanter
Durham, NC
Heung Jae Lee
Seoul, Korea
Victor Lucas
New Orleans, LA
John W. Moore
Los Angeles, CA
Victor O. Morell
Pittsburgh, PA
B.J.M. Mulder
Amsterdam, The Netherlands
Koichiro Niwa
Ichihara, Chiba, Japan
Michael D. Pettersen
Detroit, MI
Paolo Pianosi
Rochester, MN
Andrew Redington
Toronto, Ontario, Canada
Al Rocchini
Ann Arbor, MI
Jack Rychik
Philadelphia, PA
Robert E. Shaddy
Philadelphia, PA
Thomas L. Spray
Philadelphia, PA
Elizabeth Tong
Boston, MA
John Triedman
Boston, MA
Karen Uzark
Cincinnati, OH
George F. Van Hare
Palo Alto, CA
Reginald L. Washington
Lone Tree, CO
Michael White
New Orleans, LA
Thomas Young
New Orleans, LA
|
